DWA
NUVA

Dorsey Wright & Associates’s NuVasive, Inc. NUVA Stock Holding History

Dorsey Wright & Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-43,212
Closed -$3.32M – 159
2017
Q2 		$3.32M Buy
43,212
+17,450
+68% +$1.3M 1.02% 33
2017
Q1 		$1.92M Buy
+25,762
New +$1.87M 0.66% 54

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Dorsey Wright & Associates's NUVA Position: Q3 2017 in Review

Dorsey Wright & Associates sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 43,212 shares — an estimated $3.32M sold.

Dorsey Wright & Associates first reported a position in NUVA in Q1 2017 and held it in 2 quarters. The position peaked at $3.32M in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

  • Dorsey Wright & Associates reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
  • Dorsey Wright & Associates sold 43,212 NuVasive, Inc. shares in Q3 2017, an estimated $3.32M.
  • Dorsey Wright & Associates first reported a position in NuVasive, Inc. in Q1 2017 and held it in 2 quarters.
  • Dorsey Wright & Associates's NuVasive, Inc. position peaked at $3.32M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Dorsey Wright & Associates's 13F filing for Q3 2017, filed 6 Nov 2017.